These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1983462)

  • 21. Interaction of fibrinogen and asialofibrinogen with concanavalin A and clotting properties of the complexes.
    Diaz-Mauriño T; Albert A
    Biochim Biophys Acta; 1981 Nov; 677(3-4):381-9. PubMed ID: 7295803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells.
    Chowdhury ZA; Barsigian C; Chalupowicz GD; Bach TL; Garcia-Manero G; Martinez J
    Exp Cell Res; 1997 Feb; 231(1):38-49. PubMed ID: 9056410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
    Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
    J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catabolism of unglycated and naturally glycated forms of rabbit fibrinogen: their interaction with the healthy and deendothelialized aorta wall in normal and diabetic rabbits.
    Hatton MW; Southward S; Ross-Ouellet B; Richardson M; Winocour PD
    J Lab Clin Med; 1993 Apr; 121(4):588-97. PubMed ID: 8454941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-mediated endocytosis of asialoglycoproteins by rat liver hepatocytes: biochemical characterization of the endosomal compartments.
    Wall DA; Hubbard AL
    J Cell Biol; 1985 Dec; 101(6):2104-12. PubMed ID: 2866191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limitations on the specificity of targeting asialoglycoprotein-drug conjugates to hepatocytes.
    van der Sluijs P; Meijer DK
    Targeted Diagn Ther; 1991; 4():235-64. PubMed ID: 1797158
    [No Abstract]   [Full Text] [Related]  

  • 27. Altered role of microtubules in asialoglycoprotein trafficking in developing liver.
    Kaufman SS; Blain PL; Park JH; Tuma DJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G129-37. PubMed ID: 2301574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-mediated uptake of asialoglycoprotein by the primate liver initiates both lysosomal and transcellular pathways.
    Schiff JM; Huling SL; Jones AL
    Hepatology; 1986; 6(5):837-47. PubMed ID: 3758937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocytosis of asialo-glycoproteins and attachment to asialo-glycoproteins of hepatocytes from carcinogen-treated rats.
    Schwarze PE; Tolleshaug H; Seglen PO
    Toxicol Pathol; 1987; 15(1):88-92. PubMed ID: 3576077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the in vitro interaction of PNAhi lymphocytes with the bone marrow and hepatic asialoglycoprotein receptors.
    Samlowski WE; Braaten BA; Daynes RA
    Cell Immunol; 1985 Oct; 95(1):1-14. PubMed ID: 4028168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-dependent targeting of lipoproteins to specific cell types of the liver.
    Van Berkel TJ; Kruijt JK; De Smidt PC; Bijsterbosch MK
    Targeted Diagn Ther; 1991; 5():225-49. PubMed ID: 1724611
    [No Abstract]   [Full Text] [Related]  

  • 32. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers.
    Martinez J; Chalupowicz DG; Roush RK; Sheth A; Barsigian C
    Biochemistry; 1994 Mar; 33(9):2538-45. PubMed ID: 7906954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetaminophen hepatotoxicity and targeted rescue: a model for specific chemotherapy of hepatocellular carcinoma.
    Wu GY; Wu CH; Rubin MI
    Hepatology; 1985; 5(5):709-13. PubMed ID: 2993145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells.
    Cheung AL; Krishnan M; Jaffe EA; Fischetti VA
    J Clin Invest; 1991 Jun; 87(6):2236-45. PubMed ID: 1710235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic membrane receptors for glycoproteins.
    Steer CJ; Ashwell G
    Prog Liver Dis; 1986; 8():99-123. PubMed ID: 2940622
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathophysiological significance of integrin expression by vascular endothelial cells.
    van Mourik JA; von dem Borne AE; Giltay JG
    Biochem Pharmacol; 1990 Jan; 39(2):233-9. PubMed ID: 1689157
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of Kupffer cells and hepatocytes in fibrinogen catabolism].
    Davydov VS; Subkhankulova FB; Litvinov RI; Zubairov DM
    Vopr Med Khim; 1982; 28(4):83-6. PubMed ID: 7113060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catabolic properties of aglycofibrinogen synthesized by tunicamycin-treated human hepatoma (HepG2) cells and rabbit hepatocytes.
    Barsigian C; Gilman P; Base W; Fish S; Schaeffer A; Martinez J
    Biochim Biophys Acta; 1986 Oct; 883(3):552-8. PubMed ID: 3019419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen.
    Bockenstedt P; McDonagh J; Handin RI
    J Clin Invest; 1986 Aug; 78(2):551-6. PubMed ID: 2874156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.